Literature DB >> 30769212

The expansion of circulating IL-6 and IL-17-secreting follicular helper T cells is associated with neurological disabilities in neuromyelitis optica spectrum disorders.

Clarice Monteiro1, Gabriel Fernandes2, Taissa M Kasahara1, Priscila O Barros2, Aleida S O Dias1, Ana Carolina R A Araújo3, Alice M M Ornelas4, Renato S Aguiar4, Regina Alvarenga3, Cleonice A M Bento5.   

Abstract

Due to their function in assisting B cells, TFH cells may be involved in the production of pathogenic IgG in neuromyelitis optica spectrum disorder (NMOSD). In the present study, the proportion of IL-6+ and IL-17+ TFH cell subsets was higher in NMOSD patients than healthy individuals. The frequency of both TFH cell subsets were directly associated with disease activity. By contrast, NMOSD patients with a higher proportion of IL-10+ TFH cell subsets showed a lower neurological disabilities score. In summary, all findings suggest that expansion of peripheral IL-6+ and IL-17+ TFH cells may be involved in the severity of NMOSD.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aquaporin-4; Cytokines; Folicular helper T cell; Neuromyelitis optica spectrum disorders

Mesh:

Substances:

Year:  2019        PMID: 30769212     DOI: 10.1016/j.jneuroim.2019.01.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab.

Authors:  Philippe Nicolas; Anne Ruiz; Alvaro Cobo-Calvo; Guillaume Fiard; Pascale Giraudon; Sandra Vukusic; Romain Marignier
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 7.561

2.  The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder.

Authors:  Zhila Maghbooli; Abdorreza Naser Moghadasi; Nasim Rezaeimanesh; Abolfazl Omidifar; Tarlan Varzandi; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2021-04-20       Impact factor: 2.474

Review 3.  Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.

Authors:  Alessandro Dinoto; Elia Sechi; Eoin P Flanagan; Sergio Ferrari; Paolo Solla; Sara Mariotto; John J Chen
Journal:  Front Neurol       Date:  2022-03-23       Impact factor: 4.003

Review 4.  Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives.

Authors:  Tzu-Lun Huang; Jia-Kang Wang; Pei-Yao Chang; Yung-Ray Hsu; Cheng-Hung Lin; Kung-Hung Lin; Rong-Kung Tsai
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

5.  Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study.

Authors:  Linjun Cai; Ziyan Shi; Hongxi Chen; Qin Du; Ying Zhang; Zhengyang Zhao; Jiancheng Wang; Yanling Lang; Lingyao Kong; Hongyu Zhou
Journal:  Brain Sci       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.